paramount.de Traffic Analytics & Website Stats
Offizielle Webseite von Paramount Pictures Germany. Hier findest du aktuelle und zukünftige Informationen über Filme und Trailer!
paramount.de is a domain having .de extension. paramount.de is a arts and entertainment/tv movies and streaming website. paramount.de gets 26,053 traffic per month, the site is estimated to be worth $12,691.00. Over the last three months, paramount.de's global ranking has decreased from 1,396,861 to 1,691,703. paramount.de's traffic has decreased by 23.31% compared to last month, which is already a sign. Which countries sent the most traffic to paramount.de lately? Last month Germany was the top country sending traffic to paramount.de. paramount.de's audience is 69.22% male and 30.78% female. The largest age group of visitors are 25 - 34 year olds.
Updated 2 years ago
Web Analysis
- Traffic Report
-
Monthly Unique Visitors:
17,626
-
Monthly Pageviews:
26,053
- Estimated Valuation
-
Income Per Day:
$ 26
-
Estimated Worth:
$ 12,691
- Geography & Country Targeting
-
Countries Total Count:
1
-
Hot Country & Region:
Germany
- Search keywords & Backlinks
-
Keywords Total Count:
184
-
Backlinks Sites:
2
- Global Ranks
-
Global Rank:
1,691,703
-
Country Rank:
1,824
- Global Rank Change
-
Global Rank Change:
-384,318
-
Country Rank Change:
-10,855
- Web Information
- HTTP Information
- Whois Information
Web Server Information
-
Hosted IP Address:
51.255.67.10
-
Hosted Country:
FR
-
Location Latitude:
46.951740264893
-
Location Longitude:
3.1848900318146
Page Title of paramount.de
Paramount Pictures Deutschland
Meta Description of paramount.de
Offizielle Webseite von Paramount Pictures Germany. Hier findest du aktuelle und zukünftige Informationen über Filme und Trailer!
Meta Tags of paramount.de
Website Inpage Analysis
-
H1 Headings:
0
-
H2 Headings:
3
-
H3 Headings:
0
-
H4 Headings:
5
-
H5 Headings:
0
-
H6 Headings:
0
-
Total IFRAMEs:
0
-
Total Images:
7
-
Total Forms:
2
-
Total Scripts:
33
-
Google Adsense:
No Data
-
Google Analytics:
UA-34139717
HTTP Header Analysis
HTTP/1.1 200 OK
Date: Mon, 17 Oct 2022 03:40:59 GMT
Server: Apache/2.4.18 (Ubuntu)
Access-Control-Allow-Origin: *
Vary: Accept-Encoding
Content-Encoding: gzip
Cache-Control: max-age=2592000
Expires: Wed, 16 Nov 2022 03:40:59 GMT
Access-Control-Allow-Headers: Access-Control-Allow-Headers, Origin,Accept, X-Requested-With, Content-Type, Access-Control-Request-Method, Access-Control-Request-Headers, Authorization
Access-Control-Allow-Methods: GET,HEAD,OPTIONS,POST,PUT
Access-Control-Allow-Credentials: 1
Content-Length: 7352
Content-Type: text/html; charset=UTF-8
Date: Mon, 17 Oct 2022 03:40:59 GMT
Server: Apache/2.4.18 (Ubuntu)
Access-Control-Allow-Origin: *
Vary: Accept-Encoding
Content-Encoding: gzip
Cache-Control: max-age=2592000
Expires: Wed, 16 Nov 2022 03:40:59 GMT
Access-Control-Allow-Headers: Access-Control-Allow-Headers, Origin,Accept, X-Requested-With, Content-Type, Access-Control-Request-Method, Access-Control-Request-Headers, Authorization
Access-Control-Allow-Methods: GET,HEAD,OPTIONS,POST,PUT
Access-Control-Allow-Credentials: 1
Content-Length: 7352
Content-Type: text/html; charset=UTF-8
Full WHOIS Lookup
Domain: paramount.de
Status: connect
Status: connect
Similarly Ranked Websites
-
KCBD is the South Plains' breaking news and severe weather forecasting leader for Lubbock, Levelland, Brownfield, Plainview, Tahoka, Post, Crosbyton and the surrounding communities.
kcbd.com 136,739
-
American comfort food institution that's cafeteria-style for breakfast & lunch, full-serve at night.
paramountboston.com 1,588,963
-
sr2.cinema-city.pl
sr2.cinema-city.pl 17,048
-
Nikos Pekiaridis/NurPhoto via Getty Images(NEW YORK) -- Pfizer and BioNTech have launched a clinical trial on a vaccine targeting both COVID-19 and influenza, the companies announced Thursday. The phase 1 trial is being done in the United States with 180 participants between the ages of 18 and 64, with the first participant dosed this week, the companies said. The follow-up period for each participant will be six months. "By combining both indications in one vaccine approach, we aim to provide individuals with an efficient way to receive immunization against two severe respiratory diseases with evolving viruses that require vaccine adaptation," Dr. Ugur Sahin, CEO and co-founder of BioNTech, said in a statement. The combination vaccine is based on the currently available bivalent COVID-19 booster and a quadrivalent mRNA flu vaccine, which is designed to protect against four different flu viruses. The phase 1 trial will test for safety, immune response and optimal dose level of the combination vaccine, before moving on to larger trials. The data will also provide insight into the potential of mRNA vaccines to address more than one pathogen, Sahin said. Annaliesa Anderson, senior vice president and chief scientific officer of vaccine research and development for Pfizer, called this an "exciting step in our ongoing journey with BioNTech as we collectively look to transform the prevention of infectious diseases around the world." "Even with existing seasonal influenza vaccines, the burden of this virus is severe across the world causing thousands of deaths and hospitalizations every year," she said in a statement. Studies indicate COVID-19 vaccine efficacy fades over time, though it's not clear if every American will need an annual COVID-19 booster. As scientists continue to assess the need, several companies are at work on creating a single injection each fall that protects against both seasonal flu and COVID-19. In addition to Pfizer, pharmaceutical companies Moderna and Novavax have announced plans to work on a combo shot. Moderna said it anticipates starting clinical trials on a single-dose vaccine that combines a booster against COVID-19 and a booster against flu by the end of the year, with hopes of the vaccine being available for the 2023 season. "We believe this is a very large opportunity that is ahead of us, if we could bring to market a high efficacy pan-respiratory annual booster," Moderna COE Stéphane Bancel said during the Sept. 9 investor meeting. Last year, Novavax enrolled people in a Phase 1/2 study to evaluate the safety, tolerability and immune response of a combination vaccine using the company's seasonal influenza and COVID-19 vaccines. A phase 2 confirmation trial is expected to begin later this year, the company said in October. Copyright © 2022, ABC Audio. All rights reserved.
mycentraloregon.com 1,173,413
-
paramounttpa.com
paramounttpa.com 154,532
-
vupulse makes digital marketing and advertising more effective for marketers, more profitable for brands, and better experiences for consumers.
vupulse.com 414,897
-
Watch the trailer, find screenings & book tickets for Top Gun on the official site. Now Playing Only In Theatres, brought to you by Paramount Pictures. Directed by: Joseph Kosinski. Starring: Tom Cruise, Miles Teller, Jennifer Connelly, Jon Hamm, Glen Powell, Lewis Pullman, Charles Parnell, Bashir Salahuddin, Monica Barbaro, Jay Ellis, Danny Ramirez, Greg Tarzan Davis, with Ed Harris, and Val Kilmer
topgunmovie.com 199,898
-
Watch thousands of episodes of your favorite shows on any device. Paramount+ includes on-demand and live content from CBS, BET, Comedy Central, Nickelodeon, MTV, VH1, and more.
paramountplus.com 1,148
-
paramount teaching strategies & academic inputs produce toppers every year. we have been awarded the best coaching institute for bank po & ssc in north india. admission open for 2022 batch. call now.
paramountcoaching.in 3,682,910
-
paramountbooks pakistan's largest online book store. order your favorite book online from anywhere in the world.
paramountbooks.com.pk 1,758,448